Henan Lingrui Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 4.88%

Henan Lingrui Pharmaceutical Co Ltd (600285) has an Asset Resilience Ratio of 4.88% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Henan Lingrui Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥290.87 Million

≈ $42.56 Million USD Cash + Short-term Investments

Total Assets

CN¥5.97 Billion

≈ $872.97 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2025)

This chart shows how Henan Lingrui Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 600285 total assets.

Liquid Assets Composition Over Time

This chart breaks down Henan Lingrui Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Henan Lingrui Pharmaceutical Co Ltd (600285) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥290.87 Million	4.88%
Total Liquid Assets	CN¥290.87 Million	4.88%

Asset Resilience Insights

Limited Liquidity: Henan Lingrui Pharmaceutical Co Ltd maintains only 4.88% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Henan Lingrui Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Henan Lingrui Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Torrent Pharmaceuticals Limited NSE:TORNTPHARM	Drug Manufacturers - Specialty & Generic	2.79%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Harbin Pharmaceutical Group Co Ltd SHG:600664	Drug Manufacturers - Specialty & Generic	0.97%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for Henan Lingrui Pharmaceutical Co Ltd (2002–2025)

The table below shows the annual Asset Resilience Ratio data for Henan Lingrui Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.85%	CN¥160.35 Million ≈ $23.46 Million	CN¥5.64 Billion ≈ $824.65 Million	-2.80pp
2024-12-31	5.64%	CN¥283.01 Million ≈ $41.41 Million	CN¥5.02 Billion ≈ $734.12 Million	+5.64pp
2023-12-31	0.00%	CN¥206.08K ≈ $30.16K	CN¥4.77 Billion ≈ $698.28 Million	-3.46pp
2022-12-31	3.46%	CN¥150.42 Million ≈ $22.01 Million	CN¥4.34 Billion ≈ $635.72 Million	-3.92pp
2021-12-31	7.39%	CN¥280.19 Million ≈ $41.00 Million	CN¥3.79 Billion ≈ $555.05 Million	+5.73pp
2020-12-31	1.66%	CN¥57.23 Million ≈ $8.37 Million	CN¥3.46 Billion ≈ $505.98 Million	+0.82pp
2019-12-31	0.84%	CN¥27.83 Million ≈ $4.07 Million	CN¥3.32 Billion ≈ $485.20 Million	+0.56pp
2018-12-31	0.28%	CN¥8.76 Million ≈ $1.28 Million	CN¥3.11 Billion ≈ $455.09 Million	-0.01pp
2017-12-31	0.29%	CN¥9.74 Million ≈ $1.43 Million	CN¥3.31 Billion ≈ $484.00 Million	-0.14pp
2016-12-31	0.43%	CN¥12.92 Million ≈ $1.89 Million	CN¥2.98 Billion ≈ $436.29 Million	-0.28pp
2015-12-31	0.72%	CN¥19.46 Million ≈ $2.85 Million	CN¥2.71 Billion ≈ $396.36 Million	-0.06pp
2014-12-31	0.78%	CN¥19.32 Million ≈ $2.83 Million	CN¥2.47 Billion ≈ $362.09 Million	+0.30pp
2013-12-31	0.48%	CN¥7.91 Million ≈ $1.16 Million	CN¥1.65 Billion ≈ $241.17 Million	+0.06pp
2012-12-31	0.42%	CN¥5.47 Million ≈ $800.69K	CN¥1.29 Billion ≈ $189.40 Million	-0.40pp
2011-12-31	0.83%	CN¥9.99 Million ≈ $1.46 Million	CN¥1.21 Billion ≈ $176.77 Million	-0.55pp
2010-12-31	1.38%	CN¥16.53 Million ≈ $2.42 Million	CN¥1.20 Billion ≈ $175.44 Million	+0.60pp
2009-12-31	0.78%	CN¥7.94 Million ≈ $1.16 Million	CN¥1.02 Billion ≈ $149.87 Million	-0.03pp
2008-12-31	0.80%	CN¥7.79 Million ≈ $1.14 Million	CN¥968.27 Million ≈ $141.69 Million	-1.90pp
2007-12-31	2.71%	CN¥25.52 Million ≈ $3.73 Million	CN¥942.55 Million ≈ $137.92 Million	+2.17pp
2006-12-31	0.53%	CN¥4.70 Million ≈ $687.84K	CN¥878.69 Million ≈ $128.58 Million	+0.18pp
2005-12-31	0.35%	CN¥3.06 Million ≈ $448.33K	CN¥872.24 Million ≈ $127.64 Million	+0.13pp
2004-12-31	0.22%	CN¥1.80 Million ≈ $263.75K	CN¥828.81 Million ≈ $121.28 Million	+0.08pp
2003-12-31	0.13%	CN¥1.00 Million ≈ $146.33K	CN¥741.34 Million ≈ $108.48 Million	-2.62pp
2002-12-31	2.75%	CN¥19.19 Million ≈ $2.81 Million	CN¥697.75 Million ≈ $102.10 Million	--

pp = percentage points

About Henan Lingrui Pharmaceutical Co Ltd

SHG:600285 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.59 Billion

CN¥10.83 Billion CNY

Market Cap Rank

#7095 Global

#1528 in China

Share Price

CN¥19.10

Change (1 day)

-0.10%

52-Week Range

CN¥19.03 - CN¥23.48

All Time High

CN¥26.75